Ignite Creation Date:
2024-05-06 @ 1:06 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03930732
Status:
COMPLETED
Last Update Posted:
2024-02-28
First Post:
2019-04-26
Brief Title:
Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation
Sponsor:
Sanofi
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Obstructive Pulmonary Disease |
Keywords: